| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/13/2003 | WO2003011276A1 Nf?b inhibitor |
| 02/13/2003 | WO2003011274A2 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2002096855A3 Anticholinergic compounds and methods of use |
| 02/13/2003 | WO2002096457A3 Stable liquid formulations of antibodies |
| 02/13/2003 | WO2002083079A3 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002055492A3 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | US20030032827 Lipoxin compounds and their use in treating cell proliferative disorders |
| 02/13/2003 | US20030032804 Methods of treating periodontal disease |
| 02/13/2003 | US20030032670 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate |
| 02/13/2003 | US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases. |
| 02/13/2003 | US20030032642 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD. |
| 02/13/2003 | US20030032632 Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| 02/13/2003 | US20030032630 Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kappaB |
| 02/13/2003 | US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 02/13/2003 | US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030031713 Extended release oral dosage composition |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031631 Having surface tension, effective for therapy of respiratory systme disorders |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2455975A1 Mucin synthesis inhibitors |
| 02/13/2003 | CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | CA2455520A1 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | CA2450770A1 Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282599A1 Disulfide derivatives useful for treating allergic diseases |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282449A2 Treatment of human papillomavirus (hpv)-infected cells |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP0980374B1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396827A Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396254A Formula of dietotherapeutic wine for regulating functions of human body |
| 02/12/2003 | CN1395948A Medicine 'Bixueling' for treating epistaxis |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518285 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518276 Treating a p38 mediated disorders |
| 02/11/2003 | US6518274 Use of cyclopentabenzofuran-derivatives for combating (NF-κB)-dependent diseases |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | CA2320129C Suspension aerosol formulations |
| 02/11/2003 | CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers |
| 02/11/2003 | CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010297A1 Probiotic bifidobacterium strains |
| 02/06/2003 | WO2003010290A2 Novel class ii cytokine receptors and uses thereof |
| 02/06/2003 | WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/06/2003 | WO2003010168A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 02/06/2003 | WO2003010167A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010135A1 Novel phenylpropionic acid derivatives |
| 02/06/2003 | WO2003009873A2 Use of pulmonary surfactant as humectant |
| 02/06/2003 | WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/06/2003 | WO2003009855A2 Organo-phosphorous compounds for activating gamma/delta t cells |
| 02/06/2003 | WO2003009849A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |